ICD10 Disease Category |
Disease Name |
ICD10 Code |
Linked Targets |
G00-G99: Diseases of the nervous system G00-G99 |
Spinal muscular atrophy |
G00-G99 |
SMN1;SMN2 |
I00-I99: Diseases of the circulatory system |
Hypotension |
I95 |
ADRA2C |
G00-G99: Diseases of the nervous system G00-G99 |
Narcolepsy |
G47.4 |
HRH3 |
I00-I99: Diseases of the circulatory system |
Hypertension |
I10-I16 |
ADRA2C |
C00-D49: Neoplasms |
Lymphoma |
C81-C86 |
HIF1A |
E00-E89: Endocrine, nutritional and metabolic diseases |
Inflammation |
E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 |
NR3C1 |
NA: NA |
Non-infectious rhinitis |
NA |
NR3C1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Obese insulin-resistant disorders |
E11 |
HRH3 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Obesity |
E66 |
ADRA2C; HRH3 |
G00-G99: Diseases of the nervous system G00-G99 |
Neurodegenerative disease |
G30-G32 |
MAPT |
I00-I99: Diseases of the circulatory system |
Neurological disease |
I21, I22, R52, R52.1-R52.2, R60.9, G89 |
ADRA2C; HRH3 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Excessive daytime sleepiness |
F51.1, G47.1 |
HRH3 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Anxiety disorder |
F32, F40-F42 |
HRH3; NR3C1 |
NA: NA |
Corticosteroid-responsive inflammation |
NA |
NR3C1 |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Contusion |
S36.220S |
ADRA2C |
E00-E89: Endocrine, nutritional and metabolic diseases |
Metabolic disorders |
E70-E89 |
HRH3 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Eating disorder |
E66, F50, I10-I16, I50 |
HRH3 |
I00-I99: Diseases of the circulatory system |
Heart failure |
I50 |
ADRA2C |
G00-G99: Diseases of the nervous system G00-G99 |
Mild to moderate alzheimer disease |
G30 |
HRH3 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Eczema |
L20-L30 |
NR3C1 |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Poison intoxication |
T36-T50 |
ADRA2C |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Male sexual disorders |
F52 |
ADRA2C |
L00-L99: Diseases of the skin and subcutaneous tissue |
Erythema |
L51-L54 |
ADRA2C |
G00-G99: Diseases of the nervous system G00-G99 |
Epilepsy |
G40 |
HRH3 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Alcohol use disorders |
F10.2 |
ADRA2C; HRH3 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Schizophrenia |
F20 |
HRH3; HRH3 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Fibromyalgia |
M79.7 |
ADRA2C |
E00-E89: Endocrine, nutritional and metabolic diseases |
Cushing's disease |
E24.0 |
NR3C1 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Dermatitis |
L20-L30 |
NR3C1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Dementia |
F01-F07 |
HRH3; HRH3 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Depression |
F30-F39 |
ADRA2C; NR3C1 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Dermatological disease |
L00-L99 |
NR3C1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic macular edema |
E08-E13, E08.3, E09.3, E10.3, E11.3, E13.3, H35.8, R60.9 |
SERPINA6 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic nephropathy |
E11.21 |
ADRA2C |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic neuropathy |
E11.40 |
HRH3 |
H00-H59: Diseases of the eye and adnexa |
Diabetic retinopathy |
H36, E10.3, E11.3, E13.3 |
SERPINA6 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Type 2 diabetes |
E11 |
NFKB1; NR3C1 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Atopic dermatitis |
L00-L99 |
NR3C1 |
C00-D49: Neoplasms |
Cancer |
C00-C96 |
NFKB1; HIF1A; NR3C1 |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure |
Diagnostic test to differentiate primary and secondary hypothyroidism |
W88 |
TSHR |
G00-G99: Diseases of the nervous system G00-G99 |
Duchenne muscular dystrophy |
G71.0 |
NR3C1 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Rheumatoid arthritis |
M05-M06 |
NR3C1 |
I00-I99: Diseases of the circulatory system |
Pulmonary arterial hypertension |
I27.0, I27.2 |
HIF1A |
G00-G99: Diseases of the nervous system G00-G99 |
Central nervous system disease |
G00-G99 |
MAPT; HRH3 |
J00-J99: Diseases of the respiratory system |
Allergic rhinitis |
J00, J30, J31.0, T78.4 |
ADRA2C; HRH3; NR3C1 |
K00-K95: Diseases of the digestive system |
Peptic ulcer |
K25-K27 |
ADRA2C |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Cognitive disorders |
F01-F07, F04, F05, R41.3 |
MAPT; HRH3 |
J00-J99: Diseases of the respiratory system |
Asthma |
J45 |
ADRA2C; SERPINA6; NR3C1; NR3C1; NR3C1; NR3C1 |
G00-G99: Diseases of the nervous system G00-G99 |
Ataxia telangiectasia |
G11.3 |
NR3C1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Xerophthalmia |
E50.6-E50.7 |
NR3C1 |
J00-J99: Diseases of the respiratory system |
Chronic obstructive pulmonary disease |
J40-J44, J47 |
NR3C1; NR3C1; NR3C1 |
J00-J99: Diseases of the respiratory system |
Rhinitis |
J00, J30, J31.0 |
NR3C1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Attention deficit hyperactivity disorder |
F90 |
ADRA2A; HRH3 |
C00-D49: Neoplasms |
Inflammatory disease |
C11, C44, K75.9, M00-M25 |
SERPINA6; NR3C1 |
G00-G99: Diseases of the nervous system G00-G99 |
Multiple scierosis |
G35 |
NR3C1 |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Musculoskeletal pain |
R52, G89 |
HRH3 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Severe mood disorders |
F30-F39 |
NR3C1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Sexual dysfunction |
F52 |
ADRA2A |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Skin allergies |
T78.4 |
NR3C1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Sleep disorders |
F51, G47 |
HRH3 |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Spinal cord injury |
S14, S24, S34 |
NR3C1 |
C00-D49: Neoplasms |
Solid tumours |
C00-D48 |
HIF1A |
NA: NA |
Obstructive airway diseases |
NA |
SERPINA6 |
H00-H59: Diseases of the eye and adnexa |
Ocular hypertension |
H40.0 |
ADRA2C |
H00-H59: Diseases of the eye and adnexa |
Ocular disease |
H00-H59 |
ADRA2C; NR3C1 |
C00-D49: Neoplasms |
Thyroid cancer diagnosis |
C73 |
TSHR |
G00-G99: Diseases of the nervous system G00-G99 |
Alzheimer disease |
G30 |
ADRA2C; MAPT; HRH3; HRH3 |
G00-G99: Diseases of the nervous system G00-G99 |
Pain |
G64, G90.0, R52, G89 |
ADRA2C; ADRA2A; HRH3; HRH3 |
H00-H59: Diseases of the eye and adnexa |
Glaucoma |
H40-H42 |
ADRA2C |
C00-D49: Neoplasms |
Thyroid cancer |
C73 |
TSHR |
H60-H95: Diseases of the ear and mastoid process |
Otitis externa |
H60 |
NR3C1 |